Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Epivario |
Description | News home about technology addictions anxiety news team contact home about t-max™ platform pipeline team partnerships investors contact --> Dropdown L |
Keywords | N/A |
WebSite | epivario.com |
Host IP | 108.167.164.144 |
Location | United States |
Site | Rank |
US$636,518
Last updated: 2023-05-04 05:10:39
epivario.com has Semrush global rank of 16,628,452. epivario.com has an estimated worth of US$ 636,518, based on its estimated Ads revenue. epivario.com receives approximately 73,445 unique visitors each day. Its web server is located in United States, with IP address 108.167.164.144. According to SiteAdvisor, epivario.com is safe to visit. |
Purchase/Sale Value | US$636,518 |
Daily Ads Revenue | US$588 |
Monthly Ads Revenue | US$17,627 |
Yearly Ads Revenue | US$211,520 |
Daily Unique Visitors | 4,897 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
epivario.com. | A | 7199 | IP: 108.167.164.144 |
epivario.com. | NS | 86400 | NS Record: wns2040.hostgator.com. |
epivario.com. | NS | 86400 | NS Record: wns2039.hostgator.com. |
epivario.com. | MX | 14400 | MX Record: 10 alt4.aspmx.l.google.com. |
epivario.com. | MX | 14400 | MX Record: 1 aspmx.l.google.com. |
epivario.com. | MX | 14400 | MX Record: 5 alt1.aspmx.l.google.com. |
epivario.com. | MX | 14400 | MX Record: 5 alt2.aspmx.l.google.com. |
epivario.com. | MX | 14400 | MX Record: 10 alt3.aspmx.l.google.com. |
epivario.com. | TXT | 14400 | TXT Record: v=spf1 +mx +a +a:108.167.164.144 +include:websitewelcome.com ~all |
epivario.com. | TXT | 14400 | TXT Record: google-site-verification=9pKC-OwCBR1hlGAyCoyioMFn-qT6J9TFcXtWqv63HXg |
home about technology addictions anxiety news team contact home about t-max™ platform pipeline team partnerships investors contact --> Dropdown Link 1 Link 2 Link 3 --> --> EpiVario is a preclinical stage biotechnology company that is developing neuroepigenetic modulators to treat memory related psychiatric disorders. Our cofounders, Dr. Shelley Berger and Dr. Philipp Mews are leaders in the field of neuroepigenetics. Recently, they published the discovery of a key metablic enzyme, ACSS2, which functions in the nucleus of neurons to activate genes as memories are established or reconsolidated after recall (Nature, 2017 & 2019). EpiVario Inc. is pioneering epigenetic therapeutics for modern-day treatments of neuropsychiatric disorders. Spun out of the Epigenetics Institute at the University of Pennsylvania, the company develops pharmacotherapeutics that target a newly discovered epigenetic process in long-term memory. By targeting this activity to modulate stress- and |
HTTP/1.1 200 OK Date: Tue, 26 Oct 2021 07:54:38 GMT Server: Apache Upgrade: h2,h2c Connection: Upgrade Accept-Ranges: none X-Accel-Expires: 10800 Content-Type: text/html; charset=UTF-8 |
Domain Name: EPIVARIO.COM Registry Domain ID: 2177831241_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.launchpad.com Registrar URL: http://www.launchpad.com Updated Date: 2020-10-08T05:11:53Z Creation Date: 2017-10-23T15:03:07Z Registry Expiry Date: 2021-10-23T15:03:07Z Registrar: Launchpad.com Inc. Registrar IANA ID: 955 Registrar Abuse Contact Email: abuse@hostgator.com Registrar Abuse Contact Phone: 602-226-2389 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: WNS2039.HOSTGATOR.COM Name Server: WNS2040.HOSTGATOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-14T08:43:03Z <<< |